Cambridge
Joined July 2012
Tushar Kamath retweeted
Spatial genomics has existed for many years, but it has often been limited by complex imaging systems, specialized equipment, and $$$. With IRISeq, we wanted to simplify this to a simple PCR rxn. nature.com/articles/s41593-0…
5
37
7
176
31,519
Tushar Kamath retweeted
2/8 Introducing Synapse-seq: our AAV-based tool for mapping brainwide presynaptic projections or postsynaptic distributions of molecularly-defined neurons, via protein-guided RNA barcoding & single-cell/spatial readouts: doi.org/10.64898/2026.02.26.…
1
4
16
1,265
We are thrilled to have the following superstars join our fellowship program in July 2026.  Congratulations to Erik, Wes, Tushar, Brian, May and Shawna, and congratulations to the MGH GI Division for recruiting such talent.  Welcome to the family!
2
6
1
81
7,695
Tushar Kamath retweeted
The first piece of work from my PhD has now been uploaded to biorXiv! Short 🧵below:
Hunger modulates exploration through suppression of dopamine signaling in the tail of striatum biorxiv.org/cgi/content/shor… #biorxiv_neursci
7
16
2
57
18,001
Tushar Kamath retweeted
How do genetic perturbations change cells? How are these effects shaped by cell type and dosage? How do we best extract insight from modern massive perturbation atlases? Im pleased to share a new preprint where we develop a suite of statistical approaches to these Qs (link below)
8
76
7
292
101,862
Tushar Kamath retweeted
We now know the locations of cell types in a full mammalian brain. Our work reveals the brainstem’s absolutely stunning cellular complexity. How and why does it arise? Visit braincelldata.org to plot genes, localize types, and get markers. nature.com/articles/s41586-0…
2
86
1
310
38,287
Tushar Kamath retweeted
Slide-tags unifies the single cell + spatial genomics worlds. It solves three key problems with existing spatial methods: 1) Cell segmentation (the biggest problem) 2) robustness and scalability (well-powered case-control studies now possible) 3) Multiomics (ATAC, RNA, etc)
A new method called Slide-tags lets scientists capture both genetic and location information of individual cells using standard single-cell workflows in the lab. The technology builds upon Slide-seq, both developed by the labs of @insitubiology & @macosko. broad.io/slide-tags
3
42
5
275
53,074
Excited to share the next chapter of primate genomics in @Nature, where we (@illumina, @IBE_Barcelona, and @bcmhouston) created a multiple sequence alignment of 239 primate species to better understand non-coding regulatory elements! nature.com/articles/s41586-0…
1
39
2
170
39,556
Excited to announce I will be starting my lab in @BIDMCpath @BIDMC_CancerCtr at @BIDMC . Using chemical genomic approaches and thorough biochemistry we will focus on revealing new mechanisms of metabolism regulated cell death with a special focus on metal (copper) biology.
24
14
3
98
14,224
Tushar Kamath retweeted
Wow finally out in print! Great work from @emauryg and great collaborations with @freeseek82 @tkam80 and @macosko
Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions dlvr.it/StSZRB
6
1
32
4,012
Very excited to see our work on using gene features to identify target GWAS genes out at @NatureGenet
✨ ONLINE @NatureGenet 📰 Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases 🧑🏼‍🤝‍🧑🏻 Elle M. Weeks, Hilary K. Finucane and team 👇🏼 go.nature.com/3rnYnT7
1
5
35
5,496
ASO activity at single cell resolution - now published as a @NAR_Open Breakthrough article: academic.oup.com/nar/advance… Blog post on implications for prion prevention: cureffi.org/2023/05/16/asos-… Tweetstorm: xitter.cf/cureffi/status/1625800… Thank you @OnoPharmaFound for funding this 🙏
If an ASO lowers target RNA 50% in bulk brain tissue, is it 50% in all cells or 100% in half? Are cell types all impacted equally? Does CSF reflect neuronal target engagement? We did single-cell seq in ASO-treated mice & NHPs to find out doi.org/10.1101/2023.02.14.5… Thread 👇
10
30
15,993
Tushar Kamath retweeted
Excited to release our cell type atlas of the adult mouse brain! Here’s our portal: braincelldata.org And preprint: biorxiv.org/content/10.1101/… We find minimal marker sets for all cell types, explore activity-regulated genes, and perform analyses of heritability enrichment.
2
51
6
211
33,450
Tushar Kamath retweeted
Presenting Slide-TCR-seq: our method for measuring the transcriptomes of cells & T cell receptor (TCR) sequences in situ! This collaboration w/ Bryan Iorgulescu, Shuqiang Li, Catherine Wu, and @insitubiology led to some cool findings... cell.com/immunity/fulltext/S… 1/8
16
192
25
740
Tushar Kamath retweeted
Congrats to my former ⁦@Harvard⁩ bandmate ⁦@CarolynBertozzi⁩ on her ⁦@NobelPrize⁩ in chemistry! We won the Ivy League Battle of the Bands in 1986 with our rockin’ group ‘Bored Of Education’, with her on keyboards & me in spandex. news.stanford.edu/2022/10/05…
147
2,677
899
21,777
I learned in medical school that clinical trials are the best test of a hypothesis. In this week’s issue of @NEJM, two anti-synuclein trials tested the hypothesis that α-synuclein is toxic and both were negative. What keeps us from falsifying the hypothesis? (1/8)
17
73
15
241
I’ve started a Substack, called Biomarker. This week features interviews with @SchreiberStuart and Bob Langer on a life in science. I also chat with @aloktayi, CEO of @vibe_bio. Lastly, an article on cryptic splicing in #ALS dneel.substack.com – at Boston, MA
4
17
7
80
Tushar Kamath retweeted
How does a genetic variant you observe only once or twice in 400k people affect a trait? Im excited to share my first PhD manuscript, co-led with @danweiner92 and supervised by @Luke0connor, that develops a novel statistical approach to the problem of rare variant heritability
2
36
6
152